207 related articles for article (PubMed ID: 14975605)
1. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ
J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605
[TBL] [Abstract][Full Text] [Related]
2. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
3. New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus.
Matsushita M; Tsuchiya N; Oka T; Yamane A; Tokunaga K
Genes Immun; 2000 Oct; 1(7):428-34. PubMed ID: 11196673
[TBL] [Abstract][Full Text] [Related]
4. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the 2q33 and 3q21 chromosome regions including T-cell coreceptor and ligand genes may influence susceptibility to pemphigus foliaceus.
Dalla-Costa R; Pincerati MR; Beltrame MH; Malheiros D; Petzl-Erler ML
Hum Immunol; 2010 Aug; 71(8):809-17. PubMed ID: 20433886
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R
J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Wagner M; Sobczyński M; Karabon L; Bilińska M; Pokryszko-Dragan A; Pawlak-Adamska E; Cyrul M; Kuśnierczyk P; Jasek M
J Neuroimmunol; 2015 Nov; 288():79-86. PubMed ID: 26531698
[TBL] [Abstract][Full Text] [Related]
8. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease.
Gunesacar R; Erken E; Bozkurt B; Ozer HT; Dinkci S; Erken EG; Ozbalkan Z
Int J Immunogenet; 2007 Feb; 34(1):45-9. PubMed ID: 17284227
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.
Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I
Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875
[TBL] [Abstract][Full Text] [Related]
11. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I
Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
[TBL] [Abstract][Full Text] [Related]
12. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer.
Dilmec F; Ozgonul A; Uzunkoy A; Akkafa F
Int J Immunogenet; 2008 Aug; 35(4-5):317-21. PubMed ID: 18680513
[TBL] [Abstract][Full Text] [Related]
13. The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population.
Wang JJ; Jiang LQ; He B; Shi KL; Li JW; Zou LP
Int J Immunogenet; 2009 Apr; 36(2):113-8. PubMed ID: 19284445
[TBL] [Abstract][Full Text] [Related]
14. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
[TBL] [Abstract][Full Text] [Related]
15. CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.
Liu Y; Liang WB; Gao LB; Pan XM; Chen TY; Wang YY; Xue H; Zhang LS; Zhang L
Hum Immunol; 2010 Nov; 71(11):1141-6. PubMed ID: 20732370
[TBL] [Abstract][Full Text] [Related]
16. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.
Cheng TY; Lin JT; Chen LT; Shun CT; Wang HP; Lin MT; Wang TE; Cheng AL; Wu MS
J Clin Oncol; 2006 Jul; 24(21):3483-9. PubMed ID: 16849765
[TBL] [Abstract][Full Text] [Related]
17. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
[TBL] [Abstract][Full Text] [Related]
18. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders.
Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K
J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis.
Yousefipour G; Erfani N; Momtahan M; Moghaddasi H; Ghaderi A
Acta Neurol Scand; 2009 Dec; 120(6):424-9. PubMed ID: 19737153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
